Drug intelligence / Profile preview

morphine + remifentanil

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Intrathecal, Epidural
01

Overview

Morphine + remifentanil is a combination of two opioid analgesics used together primarily in anesthesia and perioperative pain management. Morphine is a naturally occurring opioid that acts as an agonist at the mu-opioid receptor, providing potent analgesia and sedation. Remifentanil is a synthetic, ultra-short-acting opioid also acting as a selective mu-opioid receptor agonist, notable for its rapid onset and offset due to metabolism by nonspecific blood and tissue esterases. The combination may be used to enhance intraoperative or postoperative pain control, particularly in settings such as cardiac surgery or intensive care where rapid titration of analgesia is required[4][5]. Both drugs act synergistically on the central nervous system to provide profound analgesia but require careful monitoring due to risks of respiratory depression and other opioid-related adverse effects.

Other names
Remifentanil plus Intrathecal MorphineRITM-IVM regimen
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on morphine + remifentanil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morphine + remifentanil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call